Improved Differentiation of hESC-Derived Pancreatic Progenitors by Using Human Fetal Pancreatic Mesenchymal Cells in a Micro-scalable Three-Dimensional Co-culture System.


Journal

Stem cell reviews and reports
ISSN: 2629-3277
Titre abrégé: Stem Cell Rev Rep
Pays: United States
ID NLM: 101752767

Informations de publication

Date de publication:
01 2022
Historique:
accepted: 16 09 2021
pubmed: 30 9 2021
medline: 22 4 2022
entrez: 29 9 2021
Statut: ppublish

Résumé

Mesenchymal cells of diverse origins differ in gene and protein expression besides producing varying effects on their organ-matched epithelial cells' maintenance and differentiation capacity. Co-culture with rodent's tissue-specific pancreatic mesenchyme accelerates proliferation, self-renewal, and differentiation of pancreatic epithelial progenitors. Therefore, in our study, the impact of three-dimensional (3D) co-culture of human fetal pancreatic-derived mesenchymal cells (hFP-MCs) with human embryonic stem cell-derived pancreatic progenitors (hESC-PPs) development towards endocrine and beta cells was assessed. Besides, the ability to maintain scalable cultures combining hFP-MCs and hESC-PPs was investigated. hFP-MCs expressed many markers in common with bone marrow-derived mesenchymal stem cells (BM-MSCs). However, they showed higher expression of DESMIN compared to BM-MSCs. After co-culture of hESC-PPs with hFP-MCs, the pancreatic progenitor (PP) spheroids generated in Matrigel had higher expression of NGN3 and INSULIN than BM-MSCs co-culture group, which shows an inductive impact of pancreatic mesenchyme on hESC-PPs beta-cells maturation. Pancreatic aggregates generated by forced aggregation through scalable AggreWell system showed similar features compared to the spheroids. These aggregates, a combination of hFP-MCs and hESC-PPs, can be applied as an appropriate tool for assessing endocrine-niche interactions and developmental processes by mimicking the pancreatic tissue.

Identifiants

pubmed: 34586606
doi: 10.1007/s12015-021-10266-z
pii: 10.1007/s12015-021-10266-z
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

360-377

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Larsen, H. L., & Grapin-Botton, A. (2017). The molecular and morphogenetic basis of pancreas organogenesis. Seminars in Cell & Developmental Biology, 66, 51–68.
Petersen, M. B., Gonçalves, C. A., Kim, Y. H., & Grapin-Botton, A. (2018) Recapitulating and deciphering human pancreas development from human pluripotent stem cells in a dish. In Current topics in developmental biology (Vol. 129, pp. 143–190). Elsevier.
Rezania, A., Bruin, J. E., Riedel, M. J., Mojibian, M., Asadi, A., Xu, J., et al. (2012). Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes, 61(8), 2016–2029. https://doi.org/10.2337/db11-1711
doi: 10.2337/db11-1711 pubmed: 22740171 pmcid: 3402300
Sneddon, J. B., Borowiak, M., & Melton, D. A. (2012). Self-renewal of embryonic-stem-cell-derived progenitors by organ-matched mesenchyme. Nature, 491(7426), 765–768.
pubmed: 23041930 pmcid: 6005657
Takebe, T., Enomura, M., Yoshizawa, E., Kimura, M., Koike, H., Ueno, Y., et al. (2015). Vascularized and complex organ buds from diverse tissues via mesenchymal cell-driven condensation. Cell Stem Cell, 16(5), 556–565.
pubmed: 25891906
Babiker, N. E., Gassoum, A., Abdelraheem, N. E., Arbab, M. A., ALDeaf, S. A. H., El-Sheikh, M. A. A., et al. (2017). The progress of stem cells in the treatment of diabetes mellitus type 1. Progress in Stem Cell, 4(01), 175–188.
D’Amour, K. A., Bang, A. G., Eliazer, S., Kelly, O. G., Agulnick, A. D., Smart, N. G., et al. (2006). Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells. Nature Biotechnology, 24(11), 1392–1401.
pubmed: 17053790
Kroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., et al. (2008). Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nature Biotechnology, 26(4), 443–452.
pubmed: 18288110
Hrvatin, S., O’Donnell, C. W., Deng, F., Millman, J. R., Pagliuca, F. W., DiIorio, P., et al. (2014). Differentiated human stem cells resemble fetal, not adult, beta cells. Proceedings of the National Academy of Sciences USA, 111(8), 3038–3043. https://doi.org/10.1073/pnas.1400709111
doi: 10.1073/pnas.1400709111
Johnson, J. D. (2016). The quest to make fully functional human pancreatic beta cells from embryonic stem cells: Climbing a mountain in the clouds. Diabetologia, 59(10), 2047–2057.
pubmed: 27473069
Nostro, M. C., Sarangi, F., Yang, C., Holland, A., Elefanty, A. G., Stanley, E. G., et al. (2015). Efficient generation of NKX6-1+ pancreatic progenitors from multiple human pluripotent stem cell lines. Stem Cell Reports, 4(4), 591–604. https://doi.org/10.1016/j.stemcr.2015.02.017
doi: 10.1016/j.stemcr.2015.02.017 pubmed: 25843049 pmcid: 4400642
Ameri, J., Borup, R., Prawiro, C., Ramond, C., Schachter, K. A., Scharfmann, R., et al. (2017). Efficient generation of glucose-responsive beta cells from isolated GP2+ human pancreatic progenitors. Cell Reports, 19(1), 36–49.
pubmed: 28380361
Nair, G. G., Liu, J. S., Russ, H. A., Tran, S., Saxton, M. S., Chen, R., et al. (2019). Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived β cells. Nature Cell Biology, 21(2), 263–274.
pubmed: 30710150 pmcid: 6746427
Davis, J. C., Alves, T. C., Helman, A., Chen, J. C., Kenty, J. H., Cardone, R. L., et al. (2020). Glucose response by stem cell-derived β cells in vitro is inhibited by a bottleneck in glycolysis. Cell Reports, 31(6), 107623.
pubmed: 32402282
Abdelalim, E. M., & Emara, M. M. (2015). Advances and challenges in the differentiation of pluripotent stem cells into pancreatic β cells. World Journal of Stem Cells, 7(1), 174–181.
pubmed: 25621117 pmcid: 4300928
Angelo, J. R., & Tremblay, K. D. (2018). Identification and fate mapping of the pancreatic mesenchyme. Developmental Biology, 435(1), 15–25.
pubmed: 29329912
Landsman, L., Nijagal, A., Whitchurch, T. J., VanderLaan, R. L., Zimmer, W. E., MacKenzie, T. C., et al. (2011). Pancreatic mesenchyme regulates epithelial organogenesis throughout development. PLoS biology, 9(9), e1001143.
pubmed: 21909240 pmcid: 3167782
Seymour, P. A., & Serup, P. (2019). Mesodermal induction of pancreatic fate commitment. Seminars in Cell & Developmental Biology, 92, 77–88.
Sakhneny, L., Khalifa-Malka, L., & Landsman, L. (2019). Pancreas organogenesis: Approaches to elucidate the role of epithelial-mesenchymal interactions. Seminars in Cell & Developmental Biology, 92, 89–96.
Guo, T., Landsman, L., Li, N., & Hebrok, M. (2013). Factors expressed by murine embryonic pancreatic mesenchyme enhance generation of insulin-producing cells from hESCs. Diabetes, 62(5), 1581–1592.
pubmed: 23305648 pmcid: 3636645
Russ, H. A., Landsman, L., Moss, C. L., Higdon, R., Greer, R. L., Kaihara, K. et al. (2016). Dynamic proteomic analysis of pancreatic mesenchyme reveals novel factors that enhance human embryonic stem cell to pancreatic cell differentiation. Stem Cells International, 2016.
Byrnes, L. E., Wong, D. M., Subramaniam, M., Meyer, N. P., Gilchrist, C. L., Knox, S. M., et al. (2018). Lineage dynamics of murine pancreatic development at single-cell resolution. Nature Communications, 9(1), 1–17.
Yung, T., Poon, F., Liang, M., Coquenlorge, S., McGaugh, E. C., Hui, C.-C., et al. (2019). Sufu-and Spop-mediated downregulation of Hedgehog signaling promotes beta cell differentiation through organ-specific niche signals. Nature Communications, 10(1), 1–17.
Cooper, T. T., Sherman, S. E., Bell, G. I., Ma, J., Kuljanin, M., Jose, S. E., et al. (2020). Characterization of a Vimentin high/Nestin high proteome and tissue regenerative secretome generated by human pancreas-derived mesenchymal stromal cells. Stem Cells, 38(5), 666–682.
pubmed: 31904137
Golosow, N., & Grobstein, C. (1962). Epitheliomesenchymal interaction in pancreatic morphogenesis. Developmental Biology, 4(2), 242–255.
pubmed: 13899987
Duvillié, B., Attali, M., Bounacer, A., Ravassard, P., Basmaciogullari, A., & Scharfmann, R. (2006). The mesenchyme controls the timing of pancreatic β-cell differentiation. Diabetes, 55(3), 582–589.
pubmed: 16505219
Attali, M., Stetsyuk, V., Basmaciogullari, A., Aiello, V., Zanta-Boussif, M. A., Duvillie, B., et al. (2007). Control of β-cell differentiation by the pancreatic mesenchyme. Diabetes, 56(5), 1248–1258.
pubmed: 17322477
Scavuzzo, M. A., Yang, D., & Borowiak, M. (2017). Organotypic pancreatoids with native mesenchyme develop Insulin producing endocrine cells. Scientific Reports, 7(1), 10810.
pubmed: 28883507 pmcid: 5589819
Trott, J., Tan, E. K., Ong, S., Titmarsh, D. M., Denil, S. L., Giam, M., et al. (2017). Long-term culture of self-renewing pancreatic progenitors derived from human pluripotent stem cells. Stem Cell Reports, 8(6), 1675–1688.
pubmed: 28591650 pmcid: 5470345
Clevers, H. (2016). Modeling development and disease with organoids. Cell, 165(7), 1586–1597.
pubmed: 27315476
Xu, H., Jiao, Y., Qin, S., Zhao, W., Chu, Q., & Wu, K. (2018). Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine. Experimental Hematology Oncology, 7(1), 30.
pubmed: 30534474 pmcid: 6282260
Ungrin, M. D., Clarke, G., Yin, T., Niebrugge, S., Nostro, M. C., Sarangi, F., et al. (2012). Rational bioprocess design for human pluripotent stem cell expansion and endoderm differentiation based on cellular dynamics. Biotechnology and Bioengineering, 109, 853–866.
pubmed: 22139975
Tran, R., Moraes, C., & Hoesli, C. A. (2020). Controlled clustering enhances PDX1 and NKX6 1. expression in pancreatic endoderm cells derived from pluripotent stem cells. Scientific Reports, 10(1), 1–12.
Bernard, A. B., Lin, C.-C., & Anseth, K. S. (2012). A microwell cell culture platform for the aggregation of pancreatic β-cells. Tissue Engineering Part C: Methods, 18(8), 583–592.
Khademhosseini, A., Ferreira, L., Blumling, J., III., Yeh, J., Karp, J. M., Fukuda, J., et al. (2006). Co-culture of human embryonic stem cells with murine embryonic fibroblasts on microwell-patterned substrates. Biomaterials, 27(36), 5968–5977.
pubmed: 16901537
Zhao, X., Qiu, X., Zhang, Y., Zhang, S., Gu, X., & Guo, H. (2016). Three-dimensional aggregates enhance the therapeutic effects of adipose mesenchymal stem cells for ischemia-reperfusion induced kidney injury in rats. Stem Cells International, 2016.
Antonchuk, J. (2013). Formation of embryoid bodies from human pluripotent stem cells using AggreWell™ plates. In Basic cell culture protocols (p. 523–533). Springer.
Baharvand, H., Ashtiani, S. K., Taee, A., Massumi, M., Valojerdi, M. R., Yazdi, P. E., et al. (2006). Generation of new human embryonic stem cell lines with diploid and triploid karyotypes. Development, Growth & Differentiation, 48(2), 117–128. https://doi.org/10.1111/j.1440-169X.2006.00851.x
doi: 10.1111/j.1440-169X.2006.00851.x
Cowan, C. A., Klimanskaya, I., McMahon, J., Atienza, J., Witmyer, J., Zucker, J. P., et al. (2004). Derivation of embryonic stem-cell lines from human blastocysts. New England Journal of Medicine, 350(13), 1353–1356.
Lipsitz, Y. Y., Woodford, C., Yin, T., Hanna, J. H., & Zandstra, P. W. (2018). Modulating cell state to enhance suspension expansion of human pluripotent stem cells. Proceedings of the National Academy of Sciences, 115(25), 6369–6374.
Rezania, A., Bruin, J. E., Arora, P., Rubin, A., Batushansky, I., Asadi, A., et al. (2014). Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nature Biotechnology, 32(11), 1121–1133. https://doi.org/10.1038/nbt.3033
doi: 10.1038/nbt.3033 pubmed: 25211370
Larijani, B., Arjmand, B., Ahmadbeigi, N., Falahzadeh, K., Soleimani, M., Sayahpour, F. A., et al. (2015). A simple and cost-effective method for isolation and expansion of human fetal pancreas derived mesenchymal stem cells. Archives of Iranian Medicine, 18(11), 770–775.
pubmed: 26497375
Evtouchenko, L., Studer, L., Spenger, C., Dreher, E., & Seiler, R. (1996). A mathematical model for the estimation of human embryonic and fetal age. Cell Transplantation, 5(4), 453–464.
pubmed: 8800513
Gonçalves, C. A., Larsen, M., Jung, S., Stratmann, J., Nakamura, A., Leuschner, M., et al. (2021). A 3D system to model human pancreas development and its reference single cell transcriptome atlas identify signaling pathways required for progenitor expansion. Nature Communications, 12(1), 1–17.
Dahlmann, J., Kensah, G., Kempf, H., Skvorc, D., Gawol, A., Elliott, D. A., et al. (2013). The use of agarose microwells for scalable embryoid body formation and cardiac differentiation of human and murine pluripotent stem cells. Biomaterials, 34(10), 2463–2471.
pubmed: 23332176
Jiajia, L., Shinghung, M., Jiacheng, Z., Jialing, W., Dilin, X., Shengquan, H., et al. (2017). Assessment of neuronal viability using fluorescein diacetate-propidium iodide double staining in cerebellar granule neuron culture. Journal of Visualized Experiments: JoVE, 123, 55442.
Ye, L., Yu, Y., & Zhao, Y. (2020). Icariin-induced miR-875-5p attenuates epithelial-mesenchymal transition by targeting hedgehog signaling in liver fibrosis. Journal of Gastroenterology Hepatology, 35(3), 482–491.
pubmed: 31617598
Jin, J., Zhang, Z., Chen, J., Liu, Y., Chen, Q., & Wang, Q. (2019). Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759. Cell Cycle, 18(22), 3125–3136.
pubmed: 31564202 pmcid: 6816411
Liu, Y., Deng, B., Zhao, Y., Xie, S., & Nie, R. (2013). Differentiated markers in undifferentiated cells: Expression of smooth muscle contractile proteins in multipotent bone marrow mesenchymal stem cells. Development, Growth and Differentiation, 55(5), 591–605.
pubmed: 23557080
Mansuroglu, T., Dudás, J., Elmaouhoub, A., Joza, T. Z., & Ramadori, G. (2009). Hepatoblast and mesenchymal cell-specific gene-expression in fetal rat liver and in cultured fetal rat liver cells. Histochemistry Cell Biology International, 132(1), 11.
Greggio, C., De Franceschi, F., Figueiredo-Larsen, M., Gobaa, S., Ranga, A., Semb, H., et al. (2013). Artificial three-dimensional niches deconstruct pancreas development in vitro. Development, 140(21), 4452–4462. https://doi.org/10.1242/dev.096628
doi: 10.1242/dev.096628 pubmed: 24130330 pmcid: 4007719
Pagliuca, F. W., Millman, J. R., Gurtler, M., Segel, M., Van Dervort, A., Ryu, J. H., et al. (2014). Generation of functional human pancreatic beta cells in vitro. Cell, 159(2), 428–439. https://doi.org/10.1016/j.cell.2014.09.040
doi: 10.1016/j.cell.2014.09.040 pubmed: 25303535 pmcid: 4617632
Takahashi, Y., Takebe, T., & Taniguchi, H. (2016). Engineering pancreatic tissues from stem cells towards therapy. Regenerative Therapy, 3, 15–23.
pubmed: 31245468 pmcid: 6581807
Li, X. Y., Wu, S. Y., & Leung, P. S. (2019). Human fetal bone marrow-derived mesenchymal stem cells promote the proliferation and differentiation of pancreatic progenitor cells and the engraftment function of islet-like cell clusters. International Journal of Molecular Sciences, 20(17), 4083.
pmcid: 6747176
Esteban-Vives, R., Ziembicki, J., Sun Choi, M., Thompson, R., Schmelzer, E., & Gerlach, J. C. (2019). Isolation and characterization of a human fetal mesenchymal stem cell population: exploring the potential for cell banking in wound healing therapies. Cell Transplantation, 28(11), 1404–1419.
pubmed: 31407589 pmcid: 6802149
Lee, O. K., Kuo, T. K., Chen, W.-M., Lee, K.-D., Hsieh, S.-L., & Chen, T.-H. (2004). Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood, 103(5), 1669–1675.
pubmed: 14576065
In ‘t Anker, P. S., Scherjon, S. A., Kleijburg-van der Keur, C., de Groot-Swings, G. M., Claas, F. H., Fibbe, W. E., et al. (2004). Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells, 22(7), 1338–1345.
Soncini, M., Vertua, E., Gibelli, L., Zorzi, F., Denegri, M., Albertini, A., et al. (2007). Isolation and characterization of mesenchymal cells from human fetal membranes. Journal of Tissue Engineering and Regenerative Medicine, 1(4), 296–305.
pubmed: 18038420
Kim, J., Breunig, M. J., Escalante, L. E., Bhatia, N., Denu, R. A., Dollar, B. A., et al. (2012). Biologic and immunomodulatory properties of mesenchymal stromal cells derived from human pancreatic islets. Cytotherapy, 14(8), 925–935.
pubmed: 22571381 pmcid: 3537170
Cozzitorto, C., Mueller, L., Ruzittu, S., Mah, N., Willnow, D., Darrigrand, J.-F. et al. (2020). A specialized niche in the pancreatic microenvironment promotes endocrine differentiation. Developmental Cell, 55(2), 150–162.
Jaramillo, M., Mathew, S., Mamiya, H., Goh, S. K., & Banerjee, I. (2014). Endothelial cells mediate islet-specific maturation of human embryonic stem cell-derived pancreatic progenitor cells. Tissue Engineering Part A, 21(1–2), 14–25.
pubmed: 24943736 pmcid: 4293092
Takahashi, Y., Sekine, K., Kin, T., Takebe, T., & Taniguchi, H. (2018). Self-condensation culture enables vascularization of tissue fragments for efficient therapeutic transplantation. Cell Reports, 23(6), 1620–1629.
pubmed: 29742420
Soltanian, A., Ghezelayagh, Z., Mazidi, Z., Halvaei, M., Mardpour, S., Ashtiani, M. K., et al. (2019). Generation of functional human pancreatic organoids by transplants of embryonic stem cell derivatives in a 3D-printed tissue trapper. Journal of Cellular Physiology, 234(6), 9564–9576.
pubmed: 30362564
Sugiyama, T., Benitez, C. M., Ghodasara, A., Liu, L., McLean, G. W., Lee, J., et al. (2013). Reconstituting pancreas development from purified progenitor cells reveals genes essential for islet differentiation. Proceedings of the National Academy of Sciences, 110(31), 12691–12696.
Greggio, C., De Franceschi, F., Figueiredo-Larsen, M., & Grapin-Botton, A. (2014). In vitro pancreas organogenesis from dispersed mouse embryonic progenitors. Journal of Visualized Experiments: JoVE, 89, 51725.
Lebreton, F., Lavallard, V., Bellofatto, K., Bonnet, R., Wassmer, C. H., Perez, L., et al. (2019). Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes. Nature Communication, 10(1), 1–12.

Auteurs

Zahra Ghezelayagh (Z)

Department of Developmental Biology, Faculty of Basic Sciences and Advanced Technologies in Biology, University of Science and Culture, ACECR, Tehran, Iran.
Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

Mahsa Zabihi (M)

Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Department of Genetics, Faculty of Basic Sciences and Advanced Technologies in Biology, University of Science and Culture, ACECR, Tehran, Iran.

Ibrahim Zarkesh (I)

Department of Cell Engineering, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

Carla A C Gonçalves (CAC)

The Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.

Michael Larsen (M)

The Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.

Newsha Hagh-Parast (N)

Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

Mohammad Pakzad (M)

Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

Massoud Vosough (M)

Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

Babak Arjmand (B)

Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Hossein Baharvand (H)

Department of Developmental Biology, Faculty of Basic Sciences and Advanced Technologies in Biology, University of Science and Culture, ACECR, Tehran, Iran.
Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

Bagher Larijani (B)

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Anne Grapin-Botton (A)

The Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.

Hamid Reza Aghayan (HR)

Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. hr.aghayan@gmail.com.

Yaser Tahamtani (Y)

Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. y.tahamtani@royan-rc.ac.ir.
Reproductive Epidemiology Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran. y.tahamtani@royan-rc.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH